Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duonika
- Development stage
- Phase 4
- Lead developer
- Valenta Pharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Duonika is a combined oral contraceptive (COC) developed and marketed by Valenta Pharmaceuticals. It is a small molecule combination therapy consisting of drospirenone, a fourth-generation progestogen, and ethinylestradiol, a synthetic estrogen. Drospirenone is unique among progestogens for its pharmacological profile, which closely mimics natural progesterone, possessing anti-mineralocorticoid and anti-androgenic activities. These properties help to counteract estrogen-related sodium retention and treat androgen-dependent conditions like acne. Duonika is primarily indicated for the prevention of pregnancy, but it is also utilized for the treatment of moderate acne vulgaris and the management of symptoms associated with premenstrual dysphoric disorder (PMDD) in women who opt for oral contraception.
- Brand names
- Duonika
- Other names
- drospirenone + ethinylestradiolДуоника
02
Targets
AR (Adrenergic receptors)ER (Estrogen receptor)MR (Mineralocorticoid receptor)PR (Progesterone receptor)
Beyond the preview
Go deeper on Duonika.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duonika.